Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)
Price and Volume
Detailed Quote| Volume | 2,668,175 |
| Open | 25.81 |
| Bid (Size) | 26.75 (100) |
| Ask (Size) | 26.89 (600) |
| Prev. Close | 25.79 |
| Today's Range | 25.55 - 27.02 |
| 52wk Range | 23.82 - 43.15 |
| Shares Outstanding | 99,581,693 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
37.8% below 52-week high
26.84
23.8252W Low
43.1552W High
1 Week
4.1% below 1-week high
25.361W Low
28.001W High
Viking Therapeutics, Inc. - Common Stock (VKTX) traded between $23.82 and $43.15 over the past 52 weeks and last traded at $26.84, 37.8% below its 52-week high. Over the past week it ranged between $25.36 and $28.00.
Past 12 Months
+0.0%
-6.0%
-21.7%
-14.3%
-24.2%
-28.0%
1W
+$0.01
1M
-$1.70
3M
-$7.42
6M
-$4.49
YTD
-$8.58
1Y
-$10.43
VKTX was -28.0% over the past year, -14.3% over six months, -24.2% year to date, +0.0% in the last week.
12 Months vs Market
VKTX
-28.0%
DIA
+9.2%
SPY
+9.7%
QQQ
+7.3%
IWM
+13.9%
Over the past 12 months VKTX returned -28.0% versus DIA (Dow) +9.2%, SPY (S&P 500) +9.7%, QQQ (Nasdaq 100) +7.3% and IWM (Russell 2000) +13.9%.
Volume & Liquidity
0.54× 3-mo avg
Today 2,668,175
3-mo avg 4.9M
1W
3.8M
1M
4.7M
3M
4.9M
6M
3.6M
YTD
3.3M
1Y
3.3M
VKTX most recently traded 2,668,175 shares against a 3-month average daily volume of 4.9M.
More News
Read More
How I'd Invest $10,000 Right Now ↗
November 04, 2026
Via The Motley Fool
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
November 03, 2026
From FN Media
Via GlobeNewswire
Viking Therapeutics Q3 Earnings Call Highlights ↗
October 29, 2026
Via MarketBeat
Topics
Earnings
Viking (VKTX) Q3 2026 Earnings Call Transcript ↗
October 29, 2026
Via The Motley Fool
Topics
Earnings
4 High-Risk Stocks Built for Big Returns ↗
October 14, 2026
Via The Motley Fool
Topics
Artificial Intelligence
3 Absurdly Cheap Stocks to Buy Before the End of 2026 ↗
October 13, 2026
Via The Motley Fool
2 Stocks That Could Soar in Q4 ↗
October 12, 2026
Via The Motley Fool
Here Are My Top 4 Stocks to Buy in October ↗
October 05, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Prediction: This Stock Could Double Over the Next 5 Years ↗
October 02, 2026
Via The Motley Fool
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
September 30, 2026
Via The Motley Fool
Topics
Initial Public Offering
3 Emerging Biotech Stocks With Significant Upside Potential ↗
September 30, 2026
Via MarketBeat
Topics
Intellectual Property
3 Non-AI Growth Stocks That Have Massive Upside ↗
September 29, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 26.84
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 11/06/26 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.67B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>